Clinical Trials Browser

lutetium Lu 177 dotatate × Gastrointestinal × 30 days × Clear all

NCT05687123 2026-03-19

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Phase 1 Recruiting

Gastrointestinal

Adenoma, Islet Cell, Pancreatic Neoplasms